entertainment -WSS

entertainment

author：knowledge 2025-09-28 00:47:55 - browse：21674

Christopher Boerner -- biotech JPM coverage from STAT — Bristol CEO Christopher Boerner Business Wire via AP

SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months. But in trying to sell the company to investors on Monday at the annual J.P. Morgan Healthcare Conference, he pointed to the company’s 150-year history.

He spoke of the “next chapter” for BMS, which saw its stock fall 27% last year, and said that the company would be going through a “period of renewal.” Basically, the tide comes in, but it also goes out. Patents on big-selling medicines expire, but new medicines will come to take their place.

Investors may not be able to view those changes with equanimity. Sales of Bristol’s top sellers will decline significantly or vanish as generic or biosimilar medicines emerge. That includes Eliquis, the blood thinner for stroke prevention that will be one of the first medications subject to price negotiation under the Inflation Reduction Act; Revlimid, the best-selling multiple myeloma medicine that Bristol acquired when it bought Celgene for $74 billion in 2019; and Opdivo, Bristol’s pioneering cancer immunotherapy, which is an $8 billion seller.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： ADA: All diabetes patients should be screened for liver condition

WSS

Cholera vaccine supply gets boost as demand surges globally

Getting Alzheimer's drug Leqembi to patients can be a challenge

Synthetic human embryos? Researchers say term is overblown

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Eating disorder hotline's move to chatbot carried cost for volunteers

explore

entertainment

Wikipedia

What does generative AI mean for health care? We asked experts

More tobacco lobbyists active in statehouses

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The simple reason for the increase in autism diagnosis

Anesthesiologist group: stop taking Ozempic before surgery

More tobacco lobbyists active in statehouses

Wildfire smoke exposes gaps in outdoor worker protections

H5N1 bird flu found in pasteurized milk: what we know

Hepatitis C has a cure — but many Americans still lack access to it

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

focus

Illumina to lay off 10% of research and development team

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

Orangutan used medicinal plant to treat wound, first time ever seen

Cholera vaccine supply gets boost as demand surges globally

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

explore

focus

hotspot

hotspot